| human | Q5 |
| P496 | ORCID iD | 0000-0002-7610-7635 |
| P2038 | ResearchGate profile ID | Julia_Knight2 |
| P214 | VIAF ID | 105405171 |
| P10832 | WorldCat Entities ID | E39PBJcwxYbPvgDGV47R4tfjG3 |
| P108 | employer | Mount Sinai Hospital, Toronto | Q13650874 |
| P734 | family name | Knight | Q1777139 |
| Knight | Q1777139 | ||
| Knight | Q1777139 | ||
| P735 | given name | Julia | Q2737173 |
| Julia | Q2737173 | ||
| P106 | occupation | epidemiologist | Q13416803 |
| P21 | sex or gender | female | Q6581072 |
| Q64115284 | 10-year performance of four models of breast cancer risk: a validation study |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q35957063 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density |
| Q31013593 | A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease risk |
| Q29417036 | A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q36044136 | A multi-wavelength, laser-based optical spectroscopy device for breast density and breast cancer risk pre-screening |
| Q46847843 | ADH3 genotype, alcohol intake and breast cancer risk |
| Q92102602 | Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool |
| Q36497745 | Accuracy of Self-Reported Breast Cancer Information among Women from the Ontario Site of the Breast Cancer Family Registry |
| Q37105163 | Accuracy of Self-Reported Screening Mammography Use: Examining Recall among Female Relatives from the Ontario Site of the Breast Cancer Family Registry |
| Q35231571 | Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q58613780 | Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC) |
| Q40195005 | Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study |
| Q30436439 | Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study |
| Q74441035 | An assessment of the influence of clinical breast examination reports on the interpretation of mammograms in a breast screening program. Ontario Breast Screening Program Radiologists Research Group |
| Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
| Q46063050 | An inverse association between ovarian cysts and breast cancer in the breast cancer family registry |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q57591516 | Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women |
| Q28291433 | Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk |
| Q45323507 | Association between transillumination breast spectroscopy and quantitative mammographic features of the breast |
| Q51388179 | Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. |
| Q38776757 | Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study |
| Q64112402 | Association of Prepubertal and Adolescent Androgen Concentrations With Timing of Breast Development and Family History of Breast Cancer |
| Q58231822 | Association of Vitamin D Related Information from a Telephone Interview with 25-Hydroxyvitamin D |
| Q37271129 | Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q33873226 | Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q34571646 | BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q34334167 | Beliefs about optimal age and screening frequency predict breast screening adherence in a prospective study of female relatives from the Ontario site of the Breast Cancer Family Registry |
| Q91375393 | Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q37430003 | Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer |
| Q50046604 | Breast Cancer Family History and Allele-Specific DNA Methylation in the Legacy Girls Study. |
| Q57420847 | Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study |
| Q35609710 | Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q26766205 | Breast cancer survival among young women: a review of the role of modifiable lifestyle factors |
| Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
| Q59789681 | CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study |
| Q44173416 | Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies |
| Q37219731 | Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC) |
| Q33314644 | Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk |
| Q36600605 | Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q37047463 | Comparison of Clinical, Maternal, and Self Pubertal Assessments: Implications for Health Studies |
| Q52579925 | Comparison of methods to assess onset of breast development in the LEGACY Girls Study: methodological considerations for studies of breast cancer. |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q34084261 | Correlation of DNA methylation levels in blood and saliva DNA in young girls of the LEGACY Girls study |
| Q37685729 | DNA mismatch repair gene MSH6 implicated in determining age at natural menopause |
| Q33588213 | Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers |
| Q38927282 | Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry |
| Q35049656 | Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the breast cancer family registry |
| Q51857405 | Estimation of mammographic density on an interval scale by transillumination breast spectroscopy. |
| Q47331743 | Ethnicity, but not cancer family history, is related to response to a population-based mailed questionnaire |
| Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q37399513 | Family history of hormonal cancers and colorectal cancer risk: a case-control study conducted in Ontario |
| Q45137915 | Family-based association study of IGF1 microsatellites and height, weight, and body mass index |
| Q51811339 | Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk. |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
| Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q44023983 | Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations |
| Q57419070 | Functional characterization of novel presenilin-2 variants identified in human breast cancers |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q35999323 | Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q34795962 | Genetic variants in vitamin d pathway genes and risk of pancreas cancer; results from a population-based case-control study in ontario, Canada |
| Q44743159 | Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q44202163 | HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q33919320 | Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population |
| Q34522623 | Human subjects protection: an event monitoring committee for research studies of girls from breast cancer families |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q35608709 | Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR) |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q51196865 | Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry. |
| Q34250215 | Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations |
| Q35443535 | Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative Family Registry for Breast Cancer Studies |
| Q35013740 | Influence of perceived breast cancer risk on screening behaviors of female relatives from the Ontario site of the Breast Cancer Family Registry |
| Q51776187 | Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q46738200 | Light and exercise and melatonin production in women |
| Q50692777 | MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. |
| Q50661115 | MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer. |
| Q74586380 | Macronutrient intake and change in mammographic density at menopause: results from a randomized trial |
| Q36027695 | Mammographic densities and breast cancer risk |
| Q78140518 | Mammographic densities and risk of breast cancer among subjects with a family history of this disease |
| Q38463411 | Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry |
| Q33293469 | Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario |
| Q40720876 | Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype. |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q37400462 | Missense polymorphisms in the adenomatous polyposis coli gene and colorectal cancer risk |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
| Q61670380 | No Association Between 25-Hydroxyvitamin D and Mammographic Density |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q44122211 | No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years |
| Q37628084 | Non-invasive optical spectroscopic monitoring of breast development during puberty |
| Q35752042 | Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures |
| Q71699294 | Occupation and risk of germ cell testicular cancer by histologic type in Ontario |
| Q34398269 | Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations |
| Q46662740 | Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
| Q73254259 | Parental occupational exposure and the risk of testicular cancer in Ontario |
| Q38073464 | Perceived risk and adherence to breast cancer screening guidelines among women with a familial history of breast cancer: a review of the literature |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q38342760 | Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. |
| Q33287624 | Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q45062920 | Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q46409286 | Predictors of 25-Hydroxyvitamin D Concentration Measured at Multiple Time Points in a Multiethnic Population |
| Q35117267 | Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients |
| Q35034717 | Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients |
| Q44871210 | Prospective association of 25(OH)D with metabolic syndrome |
| Q35405441 | Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study |
| Q37149228 | Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer |
| Q33781466 | Pubertal development in girls by breast cancer family history: the LEGACY girls cohort |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q77789475 | Putting the risk of breast cancer in perspective |
| Q90439909 | Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk |
| Q64101959 | Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study |
| Q36415317 | Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study |
| Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
| Q37632099 | Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry |
| Q36089820 | Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study |
| Q35750765 | Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry |
| Q30415050 | Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study |
| Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
| Q33242109 | SNP-SNP interactions in breast cancer susceptibility |
| Q34056853 | STROBE-ME - illuminating methodological issues for the reporting of molecular epidemiology data |
| Q35983751 | Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry |
| Q52573207 | Serum osteoprotegerin levels and mammographic density among high-risk women. |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q34380505 | Solar ultraviolet-B radiation and vitamin D: a cross-sectional population-based study using data from the 2007 to 2009 Canadian Health Measures Survey |
| Q37085141 | Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study |
| Q24806109 | The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer |
| Q44897750 | The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry |
| Q51070817 | The Cooperative Familial Registry for Breast Cancer Studies: design and first year recruitment rates in Ontario. |
| Q37686870 | The LEGACY Girls Study: Growth and Development in the Context of Breast Cancer Family History |
| Q35781316 | The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients |
| Q34973369 | The association between breast tissue optical content and mammographic density in pre- and post-menopausal women |
| Q52642368 | The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study. |
| Q37692625 | The dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer |
| Q35476902 | The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry |
| Q33654997 | Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry |
| Q44510993 | Ultraviolet sunlight exposure during adolescence and adulthood and breast cancer risk: a population-based case-control study among Ontario women |
| Q30416002 | Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population |
| Q58231837 | Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study |
| Q59538868 | Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women |
| Q43241593 | Vitamin D association with estradiol and progesterone in young women |
| Q40053954 | Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer |
| Q35068586 | Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients |
| Q59538867 | Vitamin D-Related Genetic Variants, Interactions with Vitamin D Exposure, and Breast Cancer Risk among Caucasian Women in Ontario |
| Q36082470 | Worry is good for breast cancer screening: a study of female relatives from the ontario site of the breast cancer family registry |
Search more.